Biotech Breakthroughs

Results

57

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

57 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	MDGL	US$512.65	1.4%	70.5%	US$11.8b	US$678.71	10.4	59.2%	n/a	Pharmaceuticals & Biotech
	SNDX	US$21.31	12.2%	135.7%	US$1.9b	US$39.00	8.7	68.2%	n/a	Pharmaceuticals & Biotech
	MRKR	US$1.32	-1.1%	-9.9%	US$21.9m	US$7.87	6.2	69.0%	n/a	Pharmaceuticals & Biotech
	ARDX	US$5.55	-8.3%	50.4%	US$1.4b	US$16.30	3.2	55.9%	n/a	Pharmaceuticals & Biotech
	TNYA	US$0.72	-1.8%	17.7%	US$155.7m	US$4.00	692.0	60.9%	n/a	Pharmaceuticals & Biotech
	LCTX	US$1.28	5.8%	36.9%	US$319.1m	US$5.50	21.6	72.3%	n/a	Pharmaceuticals & Biotech
	FRMM	US$5.58	10.5%	-32.8%	US$81.1m	US$9.50	8.6	127.7%	n/a	Pharmaceuticals & Biotech
	NTLA	US$16.68	6.4%	74.5%	US$2.3b	US$26.63	35.3	67.0%	n/a	Pharmaceuticals & Biotech
	CAPR	US$26.44	-6.8%	137.1%	US$1.5b	US$53.60	5.5	63.9%	n/a	Pharmaceuticals & Biotech
	RNXT	US$0.94	2.6%	-26.3%	US$42.6m	US$7.03	28.6	73.0%	n/a	Pharmaceuticals & Biotech
	ACHV	US$6.02	24.1%	170.0%	US$618.0m	US$13.80	57.9	64.3%	n/a	Pharmaceuticals & Biotech
	SPRY	US$8.54	-11.5%	-53.1%	US$848.0m	US$28.40	8.6	65.1%	n/a	Pharmaceuticals & Biotech
	ALDX	US$1.83	-6.6%	-51.7%	US$110.4m	US$7.60	2.6	65.2%	n/a	Pharmaceuticals & Biotech
	VRDN	US$17.90	7.6%	24.9%	US$2.0b	US$33.94	27.9	60.1%	n/a	Pharmaceuticals & Biotech
	CTOR	US$0.62	-7.4%	-86.2%	US$57.6m	US$4.00	10.3	59.9%	n/a	Pharmaceuticals & Biotech
	ACIU	US$2.56	6.7%	27.4%	US$254.0m	US$8.97	55.5	63.3%	n/a	Pharmaceuticals & Biotech
	HUMA	US$0.71	-23.3%	-66.6%	US$191.1m	US$2.05	94.8	60.9%	n/a	Pharmaceuticals & Biotech
	ARQT	US$27.00	3.0%	96.5%	US$3.4b	US$34.63	8.1	48.5%	n/a	Pharmaceuticals & Biotech
	CGON	US$71.96	17.8%	177.3%	US$6.3b	US$90.29	1251.6	60.1%	n/a	Pharmaceuticals & Biotech
	LGVN	US$0.72	-12.8%	-45.8%	US$22.3m	US$7.15	18.3	55.5%	n/a	Pharmaceuticals & Biotech
	INSM	US$103.38	7.9%	3.9%	US$22.4b	US$197.05	27.3	67.2%	n/a	Pharmaceuticals & Biotech
	NAMS	US$33.24	11.4%	79.0%	US$3.9b	US$50.16	172.2	65.3%	n/a	Pharmaceuticals & Biotech
	VERA	US$42.46	21.0%	87.5%	US$3.0b	US$78.00	6.1	64.5%	n/a	Pharmaceuticals & Biotech
	LRMR	US$3.66	0.5%	20.8%	US$382.0m	US$15.11	2.4	53.5%	n/a	Pharmaceuticals & Biotech

Page 1 of 2